A systematic review of dementia cost-of-illness (COI) studies in the US and Canada was conducted to explore the policy-making relevance of these studies.
MEDLINE, CINAHL, EconLit, AMED and the Cochrane Library were searched from inception to March 2010 for English-language COI articles. Content analysis was used to extract common themes about dementia cost from the conclusions of articles that passed title, abstract and full-text screening. These themes informed our exploration of the policy-making relevance of COI studies in dementia.
The literature search retrieved 961 articles and data were extracted from 46 articles. All except three articles reported data from the US; 27 articles included Alzheimer’s dementia only. Common themes pertained to general observations about dementia cost, cost drivers in dementia, caregiver cost, items that may lower dementia cost, social service cost, Medicare and Medicaid cost, and cost comparisons with other diseases.
The common themes suggest policy-oriented research for the future. However, the extracted COI studies were typically not conducted for policymaking purposes and they did not commonly provide prescriptive policy options. Researchers and policy makers need to consider whether the optimal research focus in dementia should be on programme evaluations instead of more COI studies.
Dementia Indirect Cost Informal Caregiver Respite Care Institutionalize Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Mark Oremus holds a Career Scientist Award from the Ontario Ministry of Health and Long-Term Care. He is also the McLaughlin Professor of Population and Public Health at McMaster University. S. Carolina Aguilar is a doctoral candidate in the Health Research Methodology Program at McMaster University. Her doctoral studies are supported by a research scholarship award from the Canadian Researchers at the End of Life Network (CARENET).
The authors confirm that the paper is an accurate representation of the results. The authors have no conflicts of interest to report.
Stern Y, Folstein M, Albert M, et al. Multicenter study of predictors of disease course in Alzheimer disease (the ‘predictors study’): I. Study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 1993; 7: 3–21PubMedCrossRefGoogle Scholar
Zhu CW, Scarmeas N, Torgan R, et al. Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology 2006; 66: 1021–8PubMedCrossRefGoogle Scholar
Zhu CW, Scarmeas N, Torgan R, et al. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology 2006; 67: 998–1005PubMedCrossRefGoogle Scholar
Zhu CW, Scarmeas N, Torgan R, et al. Clinical characteristics and longitudinal changes of informal cost of Alzheimer’s disease in the community. J Am Geriatr Soc 2006; 54: 1596–602PubMedCrossRefGoogle Scholar
Zhu CW, Leibman C, McLaughlin T, et al. The effects of patient function and dependence on costs of care in Alzheimer’s disease. J Am Geriatr Soc 2008; 56: 1497–503PubMedCrossRefGoogle Scholar
Zhu CW, Leibman C, McLaughlin T, et al. Patient dependence and longitudinal changes in costs of care in Alzheimer’s disease. Dement Geriatr Cogn Disord 2008; 26: 416–23PubMedCrossRefGoogle Scholar
Stern Y, Albert SM, Sano M, et al. Assessing patient dependence in Alzheimer’s disease. J Gerontol 1994; 49: M216–22CrossRefGoogle Scholar
Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797–811PubMedCrossRefGoogle Scholar
Zhu CW, Scarmeas N, Stavitsky K, et al. Comparison of costs of care between patients with Alzheimer’s disease and dementia with Lewy bodies. Alzheimers Dement 2008; 4: 280–4PubMedCrossRefGoogle Scholar
No authors listed. Costs: measuring the economic burden of Alzheimer’s disease care. J Nurs Adm 1997; 27 (1): 4–8Google Scholar
Albert SM, Glied S, Andrews H, et al. Primary care expenditures before the onset of Alzheimer’s disease. Neurology 2002; 59: 573–8PubMedCrossRefGoogle Scholar
Bynum JP, Rabins PV, Weller W, et al. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc 2004; 52: 187–94PubMedCrossRefGoogle Scholar
Ernst RL, Hay JW. The US economic and social costs of Alzheimer’s disease revisited. Am J Public Health 1994; 84: 1261–4PubMedCrossRefGoogle Scholar
Ernst RL, Hay JW, Fenn C, et al. Cognitive function and the costs of Alzheimer disease: an exploratory study. Arch Neurol 1997; 54: 687–93PubMedCrossRefGoogle Scholar
Fillenbaum G, Heyman A, Peterson BL, et al. Use and cost of hospitalization of patients with AD by stage and living arrangement: CERAD XXI. Neurology 2001; 56: 201–6PubMedCrossRefGoogle Scholar
Fillit H, Hill JW, Futterman R. Health care utilization and costs of Alzheimer’s disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. Fam Med 2002; 34: 528–35PubMedGoogle Scholar
Fillit H, Hill J. The costs of vascular dementia: a comparison with Alzheimer’s disease. J Neurol Sci 2002 Nov 15; 203–204: 35–9PubMedCrossRefGoogle Scholar
Fox PJ, Kohatsu N, Max W, et al. Estimating the costs of caring for people with Alzheimer disease in California: 2000–2040. J Public Health Policy 2001; 22: 88–97PubMedCrossRefGoogle Scholar
Frytak JR, Henk HJ, Zhao Y, et al. Health service utilization among Alzheimer’s disease patients: evidence from managed care. Alzheimers Dement 2008; 4: 361–7PubMedCrossRefGoogle Scholar
Gutterman EM, Markowitz JS, Lewis B, et al. Cost of Alzheimer’s disease and related dementia in managed-Medicare. J Am Geriatr Soc 1999; 47: 1065–71PubMedGoogle Scholar
Harrow BS, Mahoney DF, Mendelsohn AB, et al. Variation in cost of informal caregiving and formal-service use for people with Alzheimer’s disease. Am J Alzheimers Dis Other Demen 2004; 19: 299–308PubMedCrossRefGoogle Scholar
Herrmann N, Lanctot KL, Sambrook R, et al. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry 2006; 21: 972–6PubMedCrossRefGoogle Scholar
Hu TW, Huang LF, CartwrightWS. Evaluation of the costs of caring for the senile demented elderly: a pilot study. Gerontologist 1986; 26: 158–63Google Scholar
Huang LF, Cartwright WS, Hu TW. The economic cost of senile dementia in the United States, 1985. Public Health Rep 1988; 103: 3–7PubMedGoogle Scholar
Hux MJ, O’Brien BJ, Iskedjian M, et al. Relation between severity of Alzheimer’s disease and costs of caring. CMAJ 1998; 159: 457–65PubMedGoogle Scholar
Kuo TC, Zhao Y, Weir S, et al. Implications of comorbidity on costs for patients with Alzheimer disease. Med Care 2008; 46: 839–46PubMedCrossRefGoogle Scholar
Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006; 22: 1203–10PubMedCrossRefGoogle Scholar
Langa KM, Chernew ME, Kabeto MU, et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med 2001; 16: 770–8PubMedCrossRefGoogle Scholar
Leon J, Cheng CK, Neumann PJ. Alzheimer’s disease care: costs and potential savings. Health Aff (Millwood) 1998; 17: 206–16CrossRefGoogle Scholar
Leon J, Neumann PJ. The cost of Alzheimer’s disease in managed care: a cross-sectional study. Am J Manag Care 1999; 5: 867–77PubMedGoogle Scholar
Martin BC, Ricci JF, Kotzan JA, et al. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord 2000; 14: 151–9PubMedCrossRefGoogle Scholar
McCormick WC, Hardy J, Kukull WA, et al. Healthcare utilization and costs in managed care patients with Alzheimer’s disease during the last few years of life. J Am Geriatr Soc 2001; 49: 1156–60PubMedCrossRefGoogle Scholar
Menzin J, Lang K, Friedman M, et al. The economic cost of Alzheimer’s disease and related dementias to the California Medicaid program (‘Medi-Cal’) in 1995. Am J Geriatr Psychiatry 1999; 7: 300–8PubMedGoogle Scholar
Moore MJ, Zhu CW, Clipp EC. Informal costs of dementia care: estimates from the National Longitudinal Caregiver Study. J Gerontol B Psychol Sci Soc Sci 2001; 56: S219–28CrossRefGoogle Scholar
Ostbye T, Crosse E. Net economic costs of dementia in Canada. CMAJ 1994; 151: 1457–64PubMedGoogle Scholar
Sloan FA, Taylor Jr DH. Effect of Alzheimer disease on the cost of treating other diseases. Alzheimer Dis Assoc Disord 2002; 16: 137–43PubMedCrossRefGoogle Scholar
Small GW, McDonnell DD, Brooks RL, et al. The impact of symptom severity on the cost of Alzheimer’s disease. J Am Geriatr Soc 2002; 50: 321–7PubMedCrossRefGoogle Scholar
Stommel M, Collins CE, Given BA. The costs of family contributions to the care of persons with dementia. Gerontologist 1994; 34: 199–205PubMedCrossRefGoogle Scholar
Stuart B, Gruber-Baldini AL, Fahlman C, et al. Medicare cost differences between nursing home patients admitted with and without dementia. Gerontologist 2005; 45: 505–15PubMedCrossRefGoogle Scholar
Taylor Jr DH, Sloan FA. How much do persons with Alzheimer’s disease cost Medicare? J Am Geriatr Soc 2000; 48: 639–46PubMedGoogle Scholar
Taylor Jr DH, Schenkman M, Zhou J, et al. The relative effect of Alzheimer’s disease and related dementias, disability, and comorbidities on cost of care for elderly persons. J Gerontol B Psychol Sci Soc Sci 2001; 56: S285–93CrossRefGoogle Scholar
Welch HG, Walsh JS, Larson EB. The cost of institutional care in Alzheimer’s disease: nursing home and hospital use in a prospective cohort. J Am Geriatr Soc 1992; 40: 221–4PubMedGoogle Scholar
Zhao Y, Kuo TC, Weir S, et al. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer’s. BMC Health Serv Res 2008 May 22; 8: 108PubMedCrossRefGoogle Scholar
Zimmerman S, Gruber-Baldini AL, Hebel JR, et al. Nursing home characteristics related to medicare costs for residents with and without dementia. Am J Alzheimers Dis Other Demen 2008; 23: 57–65PubMedCrossRefGoogle Scholar
Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Int Med 2008; 148: 379–85PubMedGoogle Scholar